Increased follistatin levels after oral contraceptive treatment in obese and non-obese women with polycystic ovary syndrome  | Zendy

MeiJou Chen | Zendy; WeiShiung Yang | Zendy; HsinFu Chen | Zendy; Jeng-Fu Kuo | Zendy; HongNerng Ho | Zendy; YuShih Yang | Zendy; Shee–Uan Chen | Zendy

Open Access

Increased follistatin levels after oral contraceptive treatment in obese and non-obese women with polycystic ovary syndrome

Author(s) -

MeiJou Chen,

WeiShiung Yang,

HsinFu Chen,

Jeng-Fu Kuo,

HongNerng Ho,

YuShih Yang,

Shee–Uan Chen

Publication year - 2010

Publication title -

human reproduction

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.446

H-Index - 226

eISSN - 1460-2350

pISSN - 0268-1161

DOI - 10.1093/humrep/dep459

Subject(s) - medicine , follistatin , endocrinology , polycystic ovary , insulin resistance , free androgen index , luteinizing hormone , body mass index , sex hormone binding globulin , insulin , androgen , hormone

Follistatin levels have recently been considered as a marker for inflammation. Our objective was to evaluate the level of circulating follistatin and high-sensitivity C-reactive protein (hsCRP) in women with polycystic ovary syndrome (PCOS) after oral contraceptive (OC) treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research